Close Menu

NEW YORK – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues rose 84 percent year over year driven by a strong increase in billable tests.

For the three-month period ended Sept. 30, the Temple City, California-based company posted revenues of $10.3 million compared with $5.6 million a year ago. The number of billable tests delivered in the quarter grew 272 percent to 20,697, Fulgent said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.